BioCentury | Jan 5, 2017
Financial News

Financial tracks

...principal. Kumar, who is based in the firm's Boston office, was a senior director at Merck Serono Ventures...
BioCentury | Apr 14, 2014
Financial News

EpiTherapeutics financial update

...to €15.7 million ($21.2 million). Existing investors Novo Seeds; Seed Capital Denmark; Lundbeckfond Emerge; and Merck Serono Ventures...
BioCentury | May 20, 2013
Financial News

Merck KGaA financial update

...Merck expanded to €100 million ($129.7 million) its MS Ventures fund. The strategic fund (formerly Merck Serono Ventures...
BioCentury | May 20, 2013
Finance

Merck Serono's earnest money

...sufficiently differentiated and fit Merck Serono's focus in cancer, neurodegenerative, immunology, endocrinology and fertility indications. Merck Serono Ventures...
BioCentury | Apr 15, 2013
Financial News

Canbex Therapeutics completes venture financing

...Business: Autoimmune, Musculoskeletal Date completed: 4/8/13 Type: Venture financing Raised: £2.1 million ($3.2 million) Investors: Merck Serono Ventures...
BioCentury | Apr 15, 2013
Company News

Merck KGaA neurology news

...for further development. Merck Serono will invest €5 million ($6.4 million) in seed funding, and Merck Serono Ventures...
BioCentury | Apr 15, 2013
Company News

Canbex Therapeutics board of directors update

...Canbex Therapeutics Ltd. , London, U.K. Business: Autoimmune, Musculoskeletal Appointed: Nilesh Kumar, director at Merck Serono Ventures WIR Staff autoimmune Musculoskeletal...
BioCentury | Apr 1, 2013
Financial News

EpiTherapeutics completes venture financing

...Venture financing Raised: €5 million ($6.5 million) Investors: Novo Seeds; Seed Capital Denmark; Lundbeckfond Emerge; Merck Serono Ventures WIR...
BioCentury | Feb 11, 2013
Strategy

Serono's starter kit

...incubator to provide counsel on common problems faced in early stage R&D, and partners from Merck Serono Ventures...
...then presented their business plans to an investment committee comprising Merck executives and partners at Merck Serono Ventures...
...FTDP-17 ) and beta amyloid . Asceneuron received €5 million ($6.4 million) in seed funding. Merck Serono Ventures...
BioCentury | Oct 3, 2012
Company News

Merck Serono spins out newco to develop AD assets

...further development. Merck Serono will invest EUR 5 million ($6.4 million) in seed funding, and Merck Serono Ventures...
Items per page:
1 - 10 of 32
BioCentury | Jan 5, 2017
Financial News

Financial tracks

...principal. Kumar, who is based in the firm's Boston office, was a senior director at Merck Serono Ventures...
BioCentury | Apr 14, 2014
Financial News

EpiTherapeutics financial update

...to €15.7 million ($21.2 million). Existing investors Novo Seeds; Seed Capital Denmark; Lundbeckfond Emerge; and Merck Serono Ventures...
BioCentury | May 20, 2013
Financial News

Merck KGaA financial update

...Merck expanded to €100 million ($129.7 million) its MS Ventures fund. The strategic fund (formerly Merck Serono Ventures...
BioCentury | May 20, 2013
Finance

Merck Serono's earnest money

...sufficiently differentiated and fit Merck Serono's focus in cancer, neurodegenerative, immunology, endocrinology and fertility indications. Merck Serono Ventures...
BioCentury | Apr 15, 2013
Financial News

Canbex Therapeutics completes venture financing

...Business: Autoimmune, Musculoskeletal Date completed: 4/8/13 Type: Venture financing Raised: £2.1 million ($3.2 million) Investors: Merck Serono Ventures...
BioCentury | Apr 15, 2013
Company News

Merck KGaA neurology news

...for further development. Merck Serono will invest €5 million ($6.4 million) in seed funding, and Merck Serono Ventures...
BioCentury | Apr 15, 2013
Company News

Canbex Therapeutics board of directors update

...Canbex Therapeutics Ltd. , London, U.K. Business: Autoimmune, Musculoskeletal Appointed: Nilesh Kumar, director at Merck Serono Ventures WIR Staff autoimmune Musculoskeletal...
BioCentury | Apr 1, 2013
Financial News

EpiTherapeutics completes venture financing

...Venture financing Raised: €5 million ($6.5 million) Investors: Novo Seeds; Seed Capital Denmark; Lundbeckfond Emerge; Merck Serono Ventures WIR...
BioCentury | Feb 11, 2013
Strategy

Serono's starter kit

...incubator to provide counsel on common problems faced in early stage R&D, and partners from Merck Serono Ventures...
...then presented their business plans to an investment committee comprising Merck executives and partners at Merck Serono Ventures...
...FTDP-17 ) and beta amyloid . Asceneuron received €5 million ($6.4 million) in seed funding. Merck Serono Ventures...
BioCentury | Oct 3, 2012
Company News

Merck Serono spins out newco to develop AD assets

...further development. Merck Serono will invest EUR 5 million ($6.4 million) in seed funding, and Merck Serono Ventures...
Items per page:
1 - 10 of 32